Cardiac pump with speed adapted for ventricle unloading

Information

  • Patent Grant
  • 10980928
  • Patent Number
    10,980,928
  • Date Filed
    Friday, September 20, 2019
    5 years ago
  • Date Issued
    Tuesday, April 20, 2021
    3 years ago
Abstract
A blood pump system is implantable in a patient for ventricular support. A pumping chamber has an inlet for receiving blood from a ventricle of the patient. An impeller is received in the pumping chamber. A motor is coupled to the impeller for driving rotation of the impeller. A motor controller is provided for tracking systolic and diastolic phases of a cardiac cycle of the patient and supplying a variable voltage signal to the motor in a variable speed mode to produce a variable impeller speed linked to the cardiac cycle. The impeller speed comprises a ramping up to an elevated speed during the diastolic phase in order to reduce a load on the ventricle at the beginning of the systolic phase.
Description
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH

Not Applicable.


BACKGROUND OF THE INVENTION

The present invention relates in general to ventricular support pumps and controls, and, more specifically, to a ventricular assist device for reducing load applied to a weakened ventricle during the systolic phase.


Many types of circulatory assist devices are available for either short term or long term support for patients having cardiovascular disease. For example, a heart pump system known as a left ventricular assist device (LVAD) can provide long term patient support with an implantable pump associated with an externally-worn pump control unit and batteries. The LVAD improves circulation throughout the body by assisting the left side of the heart in pumping blood. One such system is the DuraHeart® LVAS system made by Terumo Heart. Inc., of Ann Arbor, Mich. The DuraHeart® system employs a centrifugal pump with a magnetically levitated impeller to pump blood from the left ventricle to the aorta. The impeller can act as a rotor of an electric motor in which a rotating magnetic field from a multiphase stator couples with the impeller and is rotated at a speed appropriate to obtain the desired blood flow through the pump.


A typical cardiac assist system includes a pumping unit, drive electronics, microprocessor control unit, and an energy source such as rechargeable batteries and/or an AC power conditioning circuit. The system is implanted during a surgical procedure in which a centrifugal pump is placed in the patient's chest. An inflow conduit is pierced into the left ventricle to supply blood to the pump. One end of an outflow conduit is mechanically fitted to the pump outlet and the other end is surgically attached to the patient's aorta by anastomosis. A percutaneous cable connects to the pump, exits the patient through an incision, and connects to the external control unit. An LVAD system may be used with or without a pacemaker.


A control system for varying pump speed to achieve a target blood flow based on physiologic conditions is shown in U.S. Pat. No. 7,160,243, issued Jan. 9, 2007, which is incorporated herein by reference in its entirety. A target blood flow rate may be established based on the patient's heart rate so that the physiologic demand is met. In one type of conventional control unit, a constant speed setpoint has been determined for the pump motor to achieve the target flow based on demand. In this type of system, the pump speed is substantially constant within an individual cardiac cycle.


Pulsatile pumping systems are also known wherein the pump speed is varied within the cardiac cycle to more closely mimic natural heart action. In one example, U.S. Pat. No. 8,096,935 to Sutton et al oscillates the speed of the pump to produce a pulsed pressure. The speed is oscillated synchronously with the natural cardiac cycle such that a pump speed is increased during systole (the time of highest flow) and decreased during diastole (the time of lowest flow).


Whether operated at a constant speed or in a pulsatile manner, it is known that when desiring to obtain a maximum unloading of a weakened ventricle the average pump speed should be increased as much as possible (so that the pump flow is increased to the point where it captures almost the entire cardiac output). Due to flow inertia, however, the pump flow lags the ventricular pressure increase occurring at the beginning of systole. Therefore, the ventricle contraction still remains isometric at the beginning of systole (i.e., the pressure inside the ventricle resists its contraction). Furthermore, an increased average pump speed increases the risk of ventricular suction, particularly at the end of systole when the ventricle could be nearly empty.


SUMMARY OF THE INVENTION

In order to make ventricular contraction easier, the pump speed is increased before the systolic phase of cardiac cycle. As a result, the intra-ventricular pressure is reduced prior to ventricular contraction allowing a weak ventricle to contract with reduced resistance. In order to prevent ventricular suction, the pump speed is reduced to before the end of systole when the ventricle is nearly empty.


In one aspect of the invention, a blood pump system is provided for implanting in a patient for ventricular support. A pumping chamber has an inlet for receiving blood from a ventricle of the patient. An impeller is received in the pumping chamber. A motor is coupled to the impeller for driving rotation of the impeller. A motor controller is provided for tracking systolic and diastolic phases of a cardiac cycle of the patient and supplying a variable voltage signal to the motor in a variable speed mode to produce a variable impeller speed linked to the cardiac cycle. The impeller speed comprises a ramping up to an elevated speed during the diastolic phase in order to reduce a load on the ventricle at the beginning of the systolic phase. In some embodiments, the impeller speed also comprises a ramping down to a reduced speed during the systolic phase to avoid collapse of the ventricle.


The variable speed mode may be comprised of a constant current mode or may be comprised of a speed control for matching impeller speed to a target speed in which the target speed ramps up to the elevated speed during the diastolic phase and ramps down to a reduced speed during the systolic phase to avoid collapse of the ventricle.


The motor controller may be configurable to provide the variable voltage signal to the motor in either the above variable speed mode or a constant speed mode. The constant speed mode maintains a substantially constant speed of the impeller over each respective cardiac cycle. A selection between the variable speed mode and the constant speed mode is determined according to a physiologic capability of the patient. This allows for selective therapy during LVAD support. For example, immediately following the implantation when the left ventricle is weak, the pump is set to operate in the constant current mode thereby providing a greater level of ventricle unloading. With the patient's recovery, the pump may be set to operate in the constant speed mode, promoting higher flow pulsatility and a more natural physiologic response to the patient's activities.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a diagram of a circulatory assist system as one example of an implantable pump employing the present invention.



FIG. 2 is an exploded, perspective view of a portion of a centrifugal pump of a type that can be used in the present invention.



FIG. 3 is a diagram showing a prior art variable speed profile synchronized with a cardiac cycle.



FIG. 4 is a diagram showing a variable speed profile of the present invention.



FIG. 5 is a diagram showing a variable speed profile in greater detail.



FIG. 6 is a block diagram showing a pump motor and control system of the present invention.



FIG. 7 is a diagram showing pump load and speed according to an embodiment using a constant current mode.





DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS

Referring to FIG. 1, a patient 10 is shown in fragmentary front elevational view. Surgically implanted either into the patient's abdominal cavity or pericardium 11 is the pumping unit 12 of a ventricular assist device. An inflow conduit (on the hidden side of unit 12) pierces the heart to convey blood from the patient's left ventricle into pumping unit 12. An outflow conduit 13 conveys blood from pumping unit 12 to the patient's aorta. A percutaneous power cable 14 extends from pumping unit 12 outwardly of the patient's body via an incision to a compact control unit 15 worn by patient 10. Control unit 15 is powered by a main battery pack 16 and/or an external AC power supply and an internal backup battery. Control unit 15 includes a commutator circuit for driving a motor within pumping unit 12.



FIG. 2 shows a centrifugal pump unit 20 having an impeller 21 and a pump housing having upper and lower halves 22a and 22b. Impeller 21 is disposed within a pumping chamber 23 over a hub 24. Impeller 21 includes a first plate or disc 25 and a second plate or disc 27 sandwiched over a plurality of vanes 26. Second disc 27 includes a plurality of embedded magnet segments 34 for interacting with a levitating magnetic field created by a levitation magnet structure (not shown) that would be disposed against or incorporated in housing 22a. First disc 25 also contains embedded magnet segments 35 for magnetically coupling with a magnetic field from a motor (not shown) disposed against or incorporated in housing 22b. Housing 22a includes an inlet 28 for receiving blood from a patient's ventricle and distributing it to vanes 26. Impeller 21 is preferably circular and has an outer circumferential edge 30. By rotatably driving impeller 21 in a pumping direction 31, the blood received at an inner edge of impeller 21 is carried to outer circumferential 30 and enters a volute region 32 within pumping chamber 23 at an increased pressure. The pressurized blood flows out from an outlet 33 formed by housing features 33a and 33b. A flow-dividing guide wall 36 may be provided within volute region 32 to help stabilize the overall flow and the forces acting on impeller 21.



FIG. 3 shows a ventricular pressure curve 40 and a ventricular volume curve 41 according to a typical cardiac cycle. A pressure pulse 42 and a volume ejection 43 correspond with a systolic phase 44. A low ventricular pressure 45 and increasing ventricular volume 46 correspond with a diastolic phase 47. The start of systole corresponds with the time that the mitral or tricuspid valve closes, and the start of diastole corresponds with the time that the aortic valve or pulmonary valve closes. Curve 48 shows a pulsatile pump flow in which the pump speed is synchronously varied in order to provide an increased speed during systolic phase 44 and a decreased speed during diastolic phase 47. As explained above, this conventional pulsatile flow does not significantly unload the ventricle at the beginning of systole.



FIGS. 4 and 5 show a first embodiment of the invention for providing a variable speed mode with certain speed changes preceding the beginning of systole 50 and the beginning of diastole 51. An impeller speed curve 52 provides a pulsatile flow between an elevated speed 53 and a reduced speed 54. Curve 49 shows a representative current vector applied to the motor by the motor controller in order to generate a corresponding target speed. Thus, an increase in current generates a speed increase and a decrease in current generates a speed decrease. The target speed includes a ramping up at segment 55 from reduced speed 54 to elevated speed 53, wherein the ramping up begins during diastole. The time of increase and the slope of the increase are configured to provide an increasing flow before systole begins to provide a reduced ventricular pressure that allows a weak ventricle to contract with reduced resistance. The controlled motor current 49 begins to increase at a time 56 which precedes systole by a time period t1. The beginning of ramping up segment 55 of the speed may lag the current increase but still occurs prior to the beginning of systole 50. Preferably, time 56 is scheduled by the motor controller at time t1 before the next expected occurrence of systole 50 such that the ramping up begins at a moment between about 50% to about 90% into the diastolic phase. Thus, denoting the length of the diastolic phase as tD, the ratio t1/tD is preferably between 0.1 and 0.5.


To help avoid collapse of the ventricle toward the end of systole or during diastole, impeller speed 52 preferably ramps down at segment 57 from elevated speed 53 to reduced speed 54. Segment 57 begins during the systolic phase of the cardiac cycle (i.e., before the beginning of diastole 51). For example, current curve 49 starts to ramp down at a time 58 which precedes start of diastole 51 by a time t2. Preferably, time 58 may be at a moment between about 50% to about 90% into the systolic phase. Thus, denoting the length of the systolic phase as ts, the ratio t1/ts is preferably between 0.1 and 0.5.


As shown in FIG. 5, an average speed 59 is maintained as the instantaneous speed varies between elevated speed 53 and reduced speed 54. Average speed 59 may be determined in a conventional manner according to the physiological state of the patient. Offsets from average speed 59 for elevated speed 53 and reduced speed 54 may be substantially constant or may also be determined according to the physiological state of the patient.


A pump system of the present invention is shown in greater detail in FIG. 6 wherein a controller 60 uses field oriented control (FOC) to supply a multiphase voltage signal to the pump motor which comprises a stator assembly 61 shown as a three-phase stator. Individual phases A, B, and C are driven by an H-bridge inverter 62 functioning as a commutation circuit driven by a pulse width modulator (PWM) circuit 63 in controller 60. A current sensing circuit 64 associated with inverter 62 measures instantaneous phase current in at least two phases providing current signals designated ia and ib. A current calculating block 65 receives the two measured currents and calculates a current ic corresponding to the third phase as known in the art. The measured currents are input to an FOC block 66 and to a current observer block 67 which estimates the position and speed of the impeller as known in the art. The impeller position and speed are input to FOC block 66.


An average target speed or rpm for operating the pump is provided by a physiological monitor 68 to FOC block 66. The average rpm may be set by a medical caregiver or may be determined according to an algorithm based on various patient parameters such heart beat. Monitor 68 may also generate a status signal for identifying whether the ventricle is in the initial, highly weakened state or whether a predetermined recovery has been obtained in the strength of the ventricle. The average rpm and the status signal are provided to a speed command calculator 70. The status signal can be used to determine whether or not the variable speed control of the invention should be used to unload the ventricle. The status signal can alternatively be externally provided to calculator 70 (e.g., by a physician via an HMI).


Command calculator 70 is coupled to a cycle tracking block 71 which maintains timing for a cardiac cycle reference. A current signal (e.g., currents ia, ib, and ic) can be used in order to detect the cardiac cycle from the instantaneous blood flow, for example. More specifically, the controller may identify the heart rate by measuring time between current peaks in the speed control mode. Then the speed decrease can start at a calculated time after the occurrence of a current peak. The speed increase can start at a calculated time after the current minimum value is to detected. This calculated time typically depends on the heart rate.


Alternatively, cycle tracking block 71 can be coupled to a pacemaker 72 in the event that the patient is using such a device. Conventional pacemakers have been constructed to continuously generate radio signals that contain information about pulse timing and other data. These sine-wave modulated signals can be received by a special receiver (not shown), where the signals are demodulated, digitized (if necessary), and transferred to cycle tracking block 71. Besides being located near the implanted pacemaker and connected by a cable or wirelessly to the controller (e.g., via BlueTooth), a receiver could be integrated with the controller or the pumping unit.


Based on the reference cycle timing from block 71, command calculator 70 determines an instantaneous speed (or magnitude of the current vector) to be used by FOC block 66. FOC block 66 generates commanded voltage output values va, vb, and vc which are input to PWM block 63. The va, vb, and vc commands may also be coupled to observer 67 for use in detecting speed and position (not shown). Thus, the speed is controlled to follow the curves shown in FIGS. 4 and 5.


In one embodiment, the timing of the speed increases and decreases are determined as follows. At a constant pacing rate (i.e., constant beat rate), the time for starting the speed acceleration (e.g., at time 56 in FIG. 4) is:

tacc(n+1)=tp(n)+60/N−t1.

where tp(n) is the time of occurrence of a pacemaker pulse time signaling the start of the current cardiac cycle; N is the heart (pulse) rate in beat/min set by a pacemaker; and tacc(n+1) is the time to increase the pump speed for the next cardiac cycle. Similarly, the time to start deceleration (e.g., at a time 58 in FIG. 4) is:

tdecel(n+1)=ta(n+1)+ts

where ts is the duration of systole. Systole typically lasts 30% to 50% of the cardiac cycle 60/N, and within a certain heart rate range it is fairly independent of the heart rate N. For example, for a heart rate N between 60-120 beats/min, ts is between 0.30 seconds and 0.25 seconds.


In an alternative embodiment, command calculator 70 and FOC block 66 are configured to operate the motor in a constant current mode (i.e., a constant torque mode). In this mode, the speed changes inversely with the pump load (i.e., the flow rate). Thus, an average speed is determined by the physiological monitor. The motor controller adjusts the current to obtain the desired average speed and to keep the current substantially constant. By keeping a constant current in the face of a load which varies within the cardiac cycle, the impeller speed automatically changes. FIG. 7 shows a load curve 75, wherein the load (i.e., flow rate) is high at 76 during systole and low at 77 during diastole. The load ramps up at 78 before the beginning of systole due to an increase of pressure within the ventricle and a decrease of pressure at the pump outlet (e.g., at the aorta). The load ramps down at 80 during the beginning of diastole.


In the current control mode, the pump flow increases (load increases) in the beginning of systole (at 78) and the speed curve 81 drops to a reduced speed 83. At the end of systole, the flow drops (at 80) and speed increases to an elevated speed 82. Thus, the speed increases and stays relatively high during diastole to help unload the ventricle by pumping out blood at the time it fills the ventricle. This is a natural behavior of the pump in the current control mode.


Either the variable speed control mode using a variable target speed or using the constant current approach of the invention can be combined with the conventional constant speed mode in order to adapt pump performance to the strength level of the patient's ventricle. In particular, the selection between the variable speed mode and the constant speed mode can be determined according to a physiologic capability of the patient. For example, the pump is set to operate in the constant current mode immediately following the implantation when the left ventricle is weak, thereby providing a greater level of ventricle unloading. With the patient's recovery, the pump may be set to operate in the constant speed mode, promoting higher flow pulsatility and a more natural physiologic response to the patient's activities.

Claims
  • 1. A blood pump, comprising: a chamber;an impeller disposed within the chamber;a motor that is configured to drive the impeller; andat least one processor that: determines a timing of a cardio cycle of a user; andvaries a speed of the motor based on the timing of the cardio cycle of the user such that a speed of the motor begins ramping down during a systolic phase of the cardio cycle.
  • 2. The blood pump of claim 1, wherein: varying the speed of the motor comprises reducing a current level applied to the motor.
  • 3. The blood pump of claim 1, wherein: an average speed of the motor is determined based on a physiological state of the user.
  • 4. The blood pump of claim 1, wherein: determining the timing of the cardio cycle comprises measuring a time between current peaks.
  • 5. The blood pump of claim 4, wherein: the speed of the motor begins ramping down starts at a time after one of the current peaks and before a current minimum value is detected.
  • 6. The blood pump of claim 1, wherein: determining the timing of the cardio cycle is based on a signal from a pacemaker.
  • 7. The blood pump of claim 1, wherein: the processor varies the speed of the motor based on the timing of the cardio cycle of the user such that a speed of the motor begins ramping up during a diastolic phase of the cardio cycle.
  • 8. A blood pump, comprising: a chamber;an impeller disposed within the chamber;a motor that is configured to drive the impeller; andat least one processor that: determines a time period of one or both of a diastolic phase or a time period of a systolic phase of a cardio cycle of a user; andramps down a speed of the motor during the systolic phase.
  • 9. The blood pump of claim 8, wherein: the speed of the motor is ramped down beginning at a time between about 50% and 90% into the systolic phase.
  • 10. The blood pump of claim 8, wherein: the speed of the motor is ramped down to a speed that is based on a physiological state of the user.
  • 11. The blood pump of claim 8, wherein: the speed of the motor is ramped down to a substantially constant reduced speed.
  • 12. The blood pump of claim 8, wherein: the speed of the motor is ramped down by reducing a current level applied to the motor.
  • 13. The blood pump of claim 8, wherein: the time period of one or both of the diastolic phase or the time period of the systolic phase is determined by measuring a time between current peaks.
  • 14. A method for controlling a motor of a blood pump, comprising: determining a timing of a cardio cycle of a user; andvarying a speed of the motor of the blood pump based on the timing of the cardio cycle of the user such that a speed of the motor begins ramping down during a systolic phase of the cardio cycle.
  • 15. The method for controlling a motor of a blood pump of claim 14, further comprising: ramping up a speed of the motor during a diastolic phase of the cardio cycle.
  • 16. The method for controlling a motor of a blood pump of claim 15, further comprising: maintaining the speed of the motor for a period of time during the diastolic phase prior to ramping up the speed of the motor.
  • 17. The method for controlling a motor of a blood pump of claim 15, wherein: ramping up the speed of the motor begins at a moment between about 50% and 90% into the diastolic phase.
  • 18. The method for controlling a motor of a blood pump of claim 15, wherein: the speed of the motor completes ramping up during the systolic phase of the cardio cycle.
  • 19. The method for controlling a motor of a blood pump of claim 14, wherein: the speed of the motor completes ramping down during a diastolic phase of the cardio cycle.
  • 20. The method for controlling a motor of a blood pump of claim 14, wherein: determining the timing of the cardio cycle is based on a signal from a current sensor of the motor.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/640,001, filed on Jun. 30, 2017, which is a continuation of U.S. application Ser. No. 13/873,551, filed on Apr. 30, 2013, now U.S. Pat. No. 9,713,663, the disclosures of which are incorporated herein by reference in its entirety, for all purposes, as if fully set forth herein.

US Referenced Citations (262)
Number Name Date Kind
1093868 Leighty Apr 1914 A
2684035 Kemp Jul 1954 A
3510229 Smith May 1970 A
3932069 Giardini et al. Jan 1976 A
3960468 Boorse et al. Jun 1976 A
4149535 Voider Apr 1979 A
4382199 Isaacson May 1983 A
4392836 Sugawara Jun 1983 A
4507048 Belenger et al. Mar 1985 A
4540402 Aigner Sep 1985 A
4549860 Yakich Oct 1985 A
4686982 Nash Aug 1987 A
4688998 Olsen et al. Aug 1987 A
4753221 Kensey et al. Jun 1988 A
4769006 Papatonakos Sep 1988 A
4790843 Carpentier et al. Dec 1988 A
4806080 Mizobuchi et al. Feb 1989 A
4817586 Wampler Apr 1989 A
4846152 Wampler et al. Jul 1989 A
4888011 Kung et al. Dec 1989 A
4895557 Moise et al. Jan 1990 A
4900227 Troup Iin Feb 1990 A
4902272 Milder et al. Feb 1990 A
4906229 Wampler Mar 1990 A
4908012 Moise et al. Mar 1990 A
4919647 Nash Apr 1990 A
4930997 Bennett Jun 1990 A
4944722 Carriker et al. Jul 1990 A
4957504 Chardack Sep 1990 A
4969865 Hwang et al. Nov 1990 A
4985014 Orejola Jan 1991 A
4995857 Arnold Feb 1991 A
5092844 Schwartz et al. Mar 1992 A
5092879 Jarvik Mar 1992 A
5106263 Irie Apr 1992 A
5106273 Lemarquand et al. Apr 1992 A
5106372 Ranford Apr 1992 A
5112202 Ozaki et al. May 1992 A
5129883 Black Jul 1992 A
5145333 Smith Sep 1992 A
5147186 Buckholtz Sep 1992 A
5112349 Summers et al. Dec 1992 A
5190528 Fonger et al. Feb 1993 A
5201679 Velte et al. Apr 1993 A
5211546 Isaacson et al. May 1993 A
5275580 Yamazaki Jan 1994 A
5290227 Pasque Jan 1994 A
5360445 Goldowsky Jan 1994 A
5290236 Mathewson Mar 1994 A
5306295 Kolff et al. Apr 1994 A
5312341 Turi May 1994 A
5332374 Kricker et al. Jul 1994 A
5346458 Afield Sep 1994 A
5350283 Nakazeki et al. Sep 1994 A
5354331 Schachar Nov 1994 A
5370509 Golding et al. Dec 1994 A
5385581 Bramm et al. Jan 1995 A
5405383 Barr Nov 1995 A
5449342 Hirose et al. Dec 1995 A
5478222 Heidelberg et al. Dec 1995 A
5504978 Meyer, III Apr 1996 A
5507629 Jarvik Apr 1996 A
5533957 Aldea Sep 1996 A
5569111 Cho et al. Oct 1996 A
5575630 Nakazawa et al. Nov 1996 A
5595762 Derrieu et al. Jan 1997 A
5643226 Cosgrove et al. Jan 1997 A
5611679 Ghosh et al. Mar 1997 A
5613935 Jarvik Mar 1997 A
5678306 Bozeman, Jr. et al. Oct 1997 A
5692882 Bozeman, Jr. et al. Dec 1997 A
5695471 Wampler Dec 1997 A
5725357 Nakazeki et al. Mar 1998 A
5738649 Macoviak Apr 1998 A
5746575 Westphal et al. May 1998 A
5746709 Rom et al. May 1998 A
5755784 Jarvik May 1998 A
5776111 Tesio Jul 1998 A
5795074 Rahman et al. Aug 1998 A
5800559 Higham et al. Sep 1998 A
5807311 Palestrant Sep 1998 A
5814011 Corace Sep 1998 A
5824069 Lemole Oct 1998 A
5749855 Reitan Dec 1998 A
5851174 Jarvik et al. Dec 1998 A
5853394 Tolkoff et al. Dec 1998 A
5890883 Golding et al. Apr 1999 A
5924848 Izraelev Jul 1999 A
5924975 Goldowsky Jul 1999 A
5928131 Prem Jul 1999 A
5938412 Israelev Aug 1999 A
5941813 Sievers et al. Aug 1999 A
5868702 Stevens et al. Sep 1999 A
5868703 Bertolero et al. Sep 1999 A
5947703 Nojiri et al. Sep 1999 A
5951263 Taylor et al. Sep 1999 A
5964694 Siess et al. Dec 1999 A
6004269 Crowley et al. Dec 1999 A
6007479 Rottenberg et al. Dec 1999 A
6030188 Nojiri et al. Feb 2000 A
6042347 Scholl et al. Mar 2000 A
6053705 Schob et al. Apr 2000 A
6066086 Antaki et al. May 2000 A
6071093 Hart Jun 2000 A
6074180 Khanwilkar et al. Jun 2000 A
6080133 Wampler Jun 2000 A
6082900 Takeuchi et al. Jul 2000 A
6100618 Schoeb et al. Aug 2000 A
6058593 Siess Sep 2000 A
6123659 leBlanc et al. Sep 2000 A
6123726 Mori et al. Sep 2000 A
6139487 Siess Oct 2000 A
6086527 Talpade Nov 2000 A
6142752 Akamatsu et al. Nov 2000 A
6143025 Stobie et al. Nov 2000 A
6146325 Lewis et al. Nov 2000 A
6149683 Lancisi et al. Nov 2000 A
6158984 Cao et al. Dec 2000 A
6171078 Schob Jan 2001 B1
6176822 Nix et al. Jan 2001 B1
6176848 Rau et al. Jan 2001 B1
6190304 Downey et al. Feb 2001 B1
6206659 Izraelev Mar 2001 B1
6254359 Aber Mar 2001 B1
6227797 Watterson et al. May 2001 B1
6227820 Jarvik May 2001 B1
6234772 Wampler et al. May 2001 B1
6234998 Wampler May 2001 B1
6247892 Kazatchkov et al. Jun 2001 B1
6264635 Wampler et al. Jul 2001 B1
6293901 Prem Sep 2001 B1
6295877 Aboul-Hosn et al. Oct 2001 B1
6319231 Andrulitis Nov 2001 B1
6245007 Bedingham et al. Dec 2001 B1
6458163 Slemker et al. Jan 2002 B1
6351048 Schob et al. Feb 2002 B1
6375607 Prem Apr 2002 B1
6422990 Prem Jul 2002 B1
6425007 Messinger Jul 2002 B1
6428464 Bolling Aug 2002 B1
6439845 Veres Aug 2002 B1
6447266 Antaki et al. Sep 2002 B2
6447441 Yu et al. Sep 2002 B1
6508777 Macoviak et al. Jan 2003 B1
6508787 Erbel et al. Jan 2003 B2
6532964 Aboul-Hosn et al. Mar 2003 B2
6533716 Schmitz-Rode et al. Mar 2003 B1
6544216 Sammler et al. Apr 2003 B1
6547519 deBlanc et al. Apr 2003 B2
6547530 Ozaki et al. Apr 2003 B2
6595762 Khanwilkar et al. Jul 2003 B2
6609883 Woodard et al. Aug 2003 B2
6623420 Reich et al. Sep 2003 B2
6641558 Aboul-Hosn et al. Nov 2003 B1
6688861 Wampler Feb 2004 B2
6692318 McBride Feb 2004 B2
6698097 Miura et al. Mar 2004 B1
6709418 Aboul-Hosn et al. Mar 2004 B1
6716189 Jarvik et al. Apr 2004 B1
6776578 Belady Aug 2004 B2
6790171 Griindeman et al. Sep 2004 B1
6794789 Siess et al. Sep 2004 B2
6808371 Niwatsukino et al. Oct 2004 B2
6817836 Nose et al. Nov 2004 B2
6860713 Hoover Jan 2005 B2
6935344 Aboul-Hosn et al. Aug 2005 B1
6926662 Aboul-Hosn et al. Sep 2005 B1
6942672 Heilman et al. Sep 2005 B2
6949066 Beamson et al. Sep 2005 B2
6974436 Aboul-Hosn et al. Dec 2005 B1
6991595 Burke et al. Jan 2006 B2
7010954 Siess et al. Mar 2006 B2
7011620 Siess Mar 2006 B1
7048681 Tsubouchi et al. May 2006 B2
7112903 Schob Sep 2006 B1
7128538 Tsubouchi et al. Oct 2006 B2
7027875 Siess et al. Nov 2006 B2
7156802 Woodard et al. Jan 2007 B2
7160243 Medvedev Jan 2007 B2
7175588 Morello Feb 2007 B2
7172551 Leasure Jun 2007 B2
7241257 Ainsworth et al. Oct 2007 B1
7331921 Viole et al. Feb 2008 B2
7335192 Keren et al. Feb 2008 B2
7431688 Wampler et al. Oct 2008 B2
7329236 Kesten et al. Dec 2008 B2
7467930 Ozaki et al. Dec 2008 B2
7470246 Mori et al. Dec 2008 B2
7491163 Viole et al. Feb 2009 B2
7575423 Wampler Aug 2009 B2
7645225 Medvedev et al. Jan 2010 B2
7699586 LaRose et al. Apr 2010 B2
7748964 Yaegashi et al. Jul 2010 B2
7731675 Aboul-Hosn et al. Aug 2010 B2
7802966 Wampler et al. Sep 2010 B2
7841976 McBride et al. Nov 2010 B2
7888242 Tanaka et al. Feb 2011 B2
7934909 Nuesser et al. May 2011 B2
7976271 LaRose et al. Jul 2011 B2
7997854 LaRose et al. Aug 2011 B2
8007254 LaRose et al. Aug 2011 B2
8096935 Sutton et al. Jan 2012 B2
8123669 Siess et al. Feb 2012 B2
8226373 Yaehashi Jul 2012 B2
8282359 Ayre et al. Oct 2012 B2
8283829 Yamamoto et al. Oct 2012 B2
8366381 Woodard et al. Feb 2013 B2
8403823 Yu et al. Mar 2013 B2
8512012 Mustafa et al. Aug 2013 B2
8652024 Yanai et al. Feb 2014 B1
9713663 Medvedev et al. Jul 2017 B2
10456513 Medvedev et al. Oct 2019 B2
20020058994 Hill et al. May 2002 A1
20020095210 Finnegan et al. Jul 2002 A1
20030023302 Moe et al. Jan 2003 A1
20030045772 Reich et al. Mar 2003 A1
20030199727 Burke et al. Oct 2003 A1
20040007515 Geyer Jan 2004 A1
20040024285 Muckter Feb 2004 A1
20040030381 Shu Feb 2004 A1
20040210305 Shu et al. Oct 2004 A1
20050089422 Ozaki et al. Apr 2005 A1
20050131271 Benkowski et al. Jun 2005 A1
20050287022 Yaehashi et al. Dec 2005 A1
20060024182 Akdis et al. Feb 2006 A1
20060055274 Kim Mar 2006 A1
20070078293 Shambaugh, Jr. Apr 2007 A1
20070134993 Tamez et al. Jun 2007 A1
20070208210 Gelfand et al. Sep 2007 A1
20070213690 Phillips et al. Sep 2007 A1
20070231135 Wampler et al. Oct 2007 A1
20070297923 Tada Dec 2007 A1
20080021394 La Rose et al. Jan 2008 A1
20080030895 Obara et al. Feb 2008 A1
20080124231 Yaegashi May 2008 A1
20090060743 McBride et al. Mar 2009 A1
20090074336 Engesser et al. Mar 2009 A1
20090171136 Shambaugh, Jr. Jul 2009 A1
20100222634 Poirier Sep 2010 A1
20100256440 Maher et al. Oct 2010 A1
20110112354 Nishimura et al. May 2011 A1
20110118766 Reichenbach et al. May 2011 A1
20110118829 Hoarau et al. May 2011 A1
20110129373 Mori Jun 2011 A1
20110243759 Ozaki et al. Oct 2011 A1
20110298304 Cotter Dec 2011 A1
20110318203 Ozaki et al. Dec 2011 A1
20120003108 Ozaki et al. Jan 2012 A1
20120016178 Woodard et al. Jan 2012 A1
20120022645 Burke Jan 2012 A1
20120035411 LaRose et al. Feb 2012 A1
20120078030 Bourque Mar 2012 A1
20120130152 Ozaki et al. May 2012 A1
20120243759 Fujisawa Sep 2012 A1
20120308363 Ozaki et al. Dec 2012 A1
20130121821 Ozaki et al. May 2013 A1
20130170970 Ozaki et al. Jul 2013 A1
20130178694 Jeffery et al. Jul 2013 A1
20130243623 Okawa et al. Sep 2013 A1
20140030122 Ozaki et al. Jan 2014 A1
20140323796 Medvedev et al. Oct 2014 A1
20150017030 Ozaki Jan 2015 A1
Foreign Referenced Citations (67)
Number Date Country
102239334 Nov 2011 CN
102341600 Feb 2012 CN
1113117 Jul 2001 EP
1495773 Jan 2005 EP
2298375 Mar 2011 EP
2372160 Oct 2011 EP
2405140 Jan 2012 EP
2461465 Jun 2012 EP
3013385 May 2016 EP
58-009535 Jan 1983 JP
61-293146 Dec 1986 JP
04-091396 Mar 1992 JP
H04-148094 May 1992 JP
05-021197 Mar 1993 JP
H06-014538 Feb 1994 JP
06-053790 Jul 1994 JP
2006-070476 Sep 1994 JP
2006-245455 Sep 1994 JP
07-014220 Mar 1995 JP
H07-042869 Aug 1995 JP
H07-509156 Oct 1995 JP
09-122228 May 1997 JP
H10-331841 Dec 1998 JP
11-244377 Sep 1999 JP
2001-309628 Nov 2001 JP
2003-135592 May 2003 JP
2004-166401 Jun 2004 JP
2004-209240 Jul 2004 JP
2004-332566 Nov 2004 JP
2004-346925 Dec 2004 JP
2005-94955 Apr 2005 JP
2005-127222 May 2005 JP
2005-245138 Sep 2005 JP
2005-270345 Oct 2005 JP
2005-270415 Oct 2005 JP
2005-287599 Oct 2005 JP
2006-167173 Jun 2006 JP
2007-002885 Jan 2007 JP
2007-043821 Feb 2007 JP
2007-089972 Apr 2007 JP
2007-089974 Apr 2007 JP
2007-215292 Aug 2007 JP
2007-247489 Sep 2007 JP
2008-011611 Jan 2008 JP
2008-104278 May 2008 JP
2008-132131 Jun 2008 JP
2008-099453 Aug 2008 JP
2008-193838 Aug 2008 JP
2008-297997 Dec 2008 JP
2008-301634 Dec 2008 JP
2006-254619 Sep 2009 JP
2010-136863 Jun 2010 JP
2012-021413 Feb 2012 JP
1993-07388 Apr 1993 WO
1996-31934 Oct 1996 WO
1997-42413 Nov 1997 WO
2005-028000 Mar 2005 WO
2005-034312 Apr 2005 WO
2009-150893 Dec 2009 WO
2009-157408 Dec 2009 WO
2010-067682 Jun 2010 WO
2010-101082 Sep 2010 WO
2011-013483 Feb 2011 WO
2011-090927 Jul 2011 WO
2012-047550 Apr 2012 WO
2014-116639 Jul 2014 WO
2014-179271 Nov 2014 WO
Non-Patent Literature Citations (16)
Entry
Asama, et al., “Suspension Performance of a Two-Axis Actively Regulated Consequent-Pole Bearingless Motor,” IEEE Transactions on Energy Conversion, vol. 28, No. 4, Dec. 2013, all pages.
Terumo Heart, Inc., “Handled With Care—Significantly Reduce the Risk of Cell Damage,” Terumo brochure, Apr. 2010, all pages.
Yamazaki, et al., “Development of a Miniature Intraventricular Axial Flow Blood Pump,” ASAIO Journal, 1993, all pages.
Kosaka, et al.; “Operating Point Control System for a Continuous Flow Artificial Heart: In Vitro Study”; ASAIO Journal 2003, all pages.
Extended European Search report dated Apr. 2, 2013 in European Patent Application No. 10748702.7, all pages.
Extended European Search report dated Nov. 19, 2012 in European Patent Application No. 10748677.1, all pages.
International Search Report and Written Opinion dated Jul. 14, 2009 in International Patent Application No. PCT/JP2009/061318, filed Jun. 22, 2009, all pages.
International Preliminary Report on Patentability dated Feb. 8, 2011 in International Patent Application No. PCT/JP2009/061318, filed Jun. 22, 2009, all pages.
International Search Report and Written Opinion dated Apr. 12, 2011 in International Patent Application No. PCT/JP2011/050925, filed Feb. 24, 2011, all pages.
International Preliminary Report on Patentability dated Sep. 18, 2012 in International Patent Application No. PCT/JP2011/050925, filed Jan. 20, 2011, all pages.
International Search Report and Written Opinion dated Apr. 12, 2011 in International Patent Application No. PCT/JP2011/054134, filed Jun. 22, 2009, all pages.
International Preliminary Report on Patentability dated Oct. 23, 2012 in International Patent Application No. PCT/JP2011/054134, filed Jun. 22, 2009, all pages.
International Search Report and Written Opinion dated Sep. 13, 2011 in International Patent Application No. PCT/JP2011/064768, filed Jun. 28, 2011 all pages.
International Preliminary Report on Patentability dated Feb. 12, 2013 in International Patent Application No. PCT/JP2011/064768, filed Jun. 28, 2011 all pages.
Extended European Search report dated Jan. 1, 2013 in European Patent Application No. 09831788.6, all pages.
Decision to Grant dated Aug. 27, 2020 in European Patent Application No. 14792355.1, 2 pages.
Related Publications (1)
Number Date Country
20200009307 A1 Jan 2020 US
Continuations (2)
Number Date Country
Parent 15640001 Jun 2017 US
Child 16577242 US
Parent 13873551 Apr 2013 US
Child 15640001 US